The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients

References

• Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019. doi:10.1038/s41571-019-0222-4.
   PubMed Web of Science ®Google Scholar
• Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov R, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562–8. doi:10.1016/j.celrep.2014.12.039.
   PubMed Web of Science ®Google Scholar
• Mollinedo F. Neutrophil Degranulation, Plasticity, and Cancer Metastasis. Trends Immunol. 2019;40(3):228–242. doi:10.1016/j.it.2019.01.006.
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009;69(4):1553–1560. doi:10.1158/0008-5472.CAN-08-1921.
   PubMed Web of Science ®Google Scholar
• Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23):2477–2490. doi:10.1056/NEJMra043172.
   PubMed Web of Science ®Google Scholar
• Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol. 2009;27(28):4709–4717. doi:10.1200/JCO.2008.18.9498.
   PubMed Web of Science ®Google Scholar
• Hu K, Lou L, Ye J, Zhang S. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis. BMJ Open. 2015;5(4):e006404. doi:10.1136/bmjopen-2014-006404.
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Knox JJ, Lin X, Simantov R, Xie W, Lawrence N, Broom R, Fay AP, Rini B, Donskov F, et al. Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy. Eur Urol. 2016;70(2):358–364. doi:10.1016/j.eururo.2016.02.033.
   PubMed Web of Science ®Google Scholar
• Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, et al. The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer. 2019;125(1):127–134. doi:10.1002/cncr.31778.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-075.
   PubMed Web of Science ®Google Scholar
• Tirouvanziam R, Diaz D, Gernez Y, Laval J, Crubezy M, Makam M An integrative approach for immune monitoring of human health and disease by advanced flow cytometry methods. Advanced Optical Flow Cytometry: Wiley-VCH Verlag GmbH & Co. KGaA; 2011. p. 333–362.
   Google Scholar
• Jackaman C, Tomay F, Duong L, Abdol Razak NB, Pixley FJ, Metharom P, Nelson DJ. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–116. doi:10.1016/j.arr.2017.03.008.
   PubMed Web of Science ®Google Scholar
• Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384(9945):755–765. doi:10.1016/S0140-6736(14)60892-8.
   PubMed Web of Science ®Google Scholar
• Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, O’Mahony D, Lord JM. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. 2001;70:881–886.
   PubMed Web of Science ®Google Scholar
• Rice CM, Davies LC, Subleski JJ, Maio N, Gonzalez-Cotto M, Andrews C, Patel NL, Palmieri EM, Weiss JM, Lee J-M, et al. Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression. Nat Commun. 2018;9(1):5099. doi:10.1038/s41467-018-07505-2.
   PubMed Web of Science ®Google Scholar
• Siewierska K, Malicka I, Kobierzycki C, Paslawska U, Cegielski M, Grzegrzolka J, Piotrowska A, Podhorska-Okolow M, Dziegiel P, Wozniewski M, et al. The impact of exercise training on breast cancer. In Vivo. 2018;32(2):249–254. doi:10.21873/invivo.11231.
   PubMed Web of Science ®Google Scholar
• Kim J, Choi WJ, Jeong SH. The effects of physical activity on breast cancer survivors after diagnosis. J Cancer Prev. 2013;18(3):193–200. doi:10.15430/JCP.2013.18.3.193.
   PubMedGoogle Scholar
• Graf C, Wessely N. Physical Activity in the Prevention and Therapy of Breast Cancer. Breast Care (Basel). 2010;5(6):389–394. doi:10.1159/000322650.
   PubMed Web of Science ®Google Scholar
• Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, Wolinska E, Gaj P, Grazul M, Pilch Z, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019;10(1):3000. doi:10.1038/s41467-019-10979-3.
   PubMed Web of Science ®Google Scholar
• Lu H, Xu S, Liang X, Dai Y, Huang Z, Ren Y, Lin J, Liu X. Advanced glycated end products alter neutrophil effect on regulation of CD4+ T cell differentiation through induction of myeloperoxidase and neutrophil elastase activities. Inflammation. 2019;42(2):559–571. doi:10.1007/s10753-018-0913-5.
   PubMed Web of Science ®Google Scholar
• Steggerda SM, Bennett MK, Chen J, Emberley E, Huang T, Janes JR, Li W, MacKinnon AL, Makkouk A, Marguier G, et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J Immunother Cancer. 2017;5(1):101. doi:10.1186/s40425-017-0308-4.
   PubMed Web of Science ®Google Scholar
• Tateosian NL, Reiteri RM, Amiano NO, Costa MJ, Villalonga X, Guerrieri D, Maffía PC. Neutrophil elastase treated dendritic cells promote the generation of CD4+FOXP3+ regulatory T cells in vitro. Cell Immunol. 2011;269(2):128–134. doi:10.1016/j.cellimm.2011.03.013.
   PubMed Web of Science ®Google Scholar
• Lalani AKA, Xie W, Martini DJ, Steinharter JA, Norton CK, Krajewski KM, Duquette A, Bossé D, Bellmunt J, Van Allen EM, et al. Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. J Immunother Cancer. 2018;6(1):5. doi:10.1186/s40425-018-0315-0.
   PubMed Web of Science ®Google Scholar
• Azuma T, Matayoshi Y, Nagase Y, Oshi M. Neutrophil number after interferon-alfa treatment is an independent predictive marker of overall survival in metastatic renal cell carcinoma. Clin Genitourin Cancer. 2012;10(3):180–184. doi:10.1016/j.clgc.2012.03.006.
   PubMed Web of Science ®Google Scholar
• Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. Int Immunopharmacol. 2011;11(7):856–861. doi:10.1016/j.intimp.2011.01.030.
   PubMed Web of Science ®Google Scholar